1-8 of 8
Authors: Daniel R Wahl
Journal Article
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition Get access
Neuro-Oncology, noaf097, https://doi.org/10.1093/neuonc/noaf097
Published: 10 April 2025
Journal Article
DNAR-08. THY1 MEDIATES TREATMENT RESISTANCE IN GLIOBLASTOMA THROUGH RAPID REPAIR OF DNA DAMAGE Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii118–viii119, https://doi.org/10.1093/neuonc/noae165.0459
Published: 11 November 2024
Journal Article
TMET-28. RECIPROCAL LINKS BETWEEN METHIONINE METABOLISM, DNA REPAIR AND THERAPY RESISTANCE IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii294, https://doi.org/10.1093/neuonc/noae165.1166
Published: 11 November 2024
Journal Article
TMET-03. REPROGRAMMING OF GLIOBLASTOMA GLUCOSE METABOLISM FUELS TUMOR GROWTH Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v273, https://doi.org/10.1093/neuonc/noad179.1047
Published: 10 November 2023
Journal Article
DNAR-02. MICROGLIA IN THE GLIOBLASTOMA MICROENVIRONMENT ASSIST REPAIR OF RADIATION INDUCED DNA DAMAGE IN A CONTACT INDEPENDENT MANNER Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v98, https://doi.org/10.1093/neuonc/noad179.0368
Published: 10 November 2023
Journal Article
M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance Free
Neuro-Oncology, Volume 25, Issue 11, November 2023, Pages 1989–2000, https://doi.org/10.1093/neuonc/noad103
Published: 05 June 2023
Journal Article
Response assessment during chemoradiation using a hypercellular/hyperperfused imaging phenotype predicts survival in patients with newly diagnosed glioblastoma Free
Neuro-Oncology, Volume 23, Issue 9, September 2021, Pages 1537–1546, https://doi.org/10.1093/neuonc/noab038
Published: 18 February 2021
Journal Article
Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma Free
Neuro-Oncology, Volume 21, Issue 9, September 2019, Pages 1141–1149, https://doi.org/10.1093/neuonc/noz090
Published: 23 May 2019
